{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:51:20Z","timestamp":1776059480833,"version":"3.50.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl. Int."],"abstract":"<jats:p>The current allocation system does not account for liver etiology in simultaneous liver-kidney transplantation (SLKT). This study aims to assess differences in waitlist outcomes among major liver disease groups (alcohol-related liver disease [ALD], metabolic dysfunction-associated steatohepatitis [MASH], hepatitis C virus infection, and biliary diseases) in SLKT using Organ Procurement and Transplantation Network (OPTN) registry. In total, 4,846 adult SLKT candidates listed between January 2018 and March 2024 were enrolled. Patients with MASH had worse waitlist 1-year mortality compared to ALD adjusted for patient characteristics at listing (HR 1.300, 95% CI 1.059\u20131.597, p = 0.012), whereas the 1-year SLKT probability was comparable. When patients were categorized by MELD score at listing (6\u201320, 21\u201329, and \u226530), patients with MASH had significantly higher 1-year waitlist mortality compared to those with ALD in the middle MELD score group (HR 1.365, 95% CI 1.008\u20131.834, p = 0.044). Prior to the allocation policy change in 2020, patients with MASH experienced higher waitlist mortality compared to ALD, however, this disparity was not observed following the policy change. Waitlist outcomes varied significantly depending on the etiology in SLKT. The revised 2020 allocation policy may be temporally associated with changes in mortality disparities across different liver etiologies.<\/jats:p>","DOI":"10.3389\/ti.2026.16153","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:10:15Z","timestamp":1776057015000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring Disease-Specific Waitlist Outcomes in Simultaneous Liver-Kidney Transplantation"],"prefix":"10.3389","volume":"39","author":[{"given":"Rikako","family":"Oki","sequence":"first","affiliation":[{"name":"Transplant Institute, Henry Ford Hospital","place":["Detroit, MI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luckshi","family":"Rajendran","sequence":"additional","affiliation":[{"name":"Division of Transplant and Hepatobiliary Surgery Henry Ford Hospital","place":["Detroit, MI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean Yonghoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Transplant and Hepatobiliary Surgery Henry Ford Hospital","place":["Detroit, MI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Division of Transplant and Hepatobiliary Surgery Henry Ford Hospital","place":["Detroit, MI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwan","family":"Abouljoud","sequence":"additional","affiliation":[{"name":"Division of Transplant and Hepatobiliary Surgery Henry Ford Hospital","place":["Detroit, MI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Nagai","sequence":"additional","affiliation":[{"name":"Transplant Institute, Henry Ford Hospital","place":["Detroit, MI, United States"]},{"name":"Division of Transplant and Hepatobiliary Surgery Henry Ford Hospital","place":["Detroit, MI, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/tri.13388","article-title":"Simultaneous Liver Kidney Transplantation","volume":"32","author":"Singal","year":"2019","journal-title":"Transpl Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40472-018-0175-z","article-title":"Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting List","volume":"5","author":"Miles","year":"2018","journal-title":"Curr Transpl Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1016\/j.ajt.2025.01.022","article-title":"OPTN\/SRTR 2023 Annual Data Report: Liver","volume":"25","author":"Kwong","year":"2025","journal-title":"Am J Transpl"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e934850","DOI":"10.12659\/aot.934850","article-title":"Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network\/United Network for Organ Sharing Policy in the United States","volume":"27","author":"Shimada","year":"2022","journal-title":"Ann Transpl"},{"key":"B5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/tri.13814","article-title":"Disease-Specific Waitlist Outcomes in Liver Transplantation - A Retrospective Study","volume":"34","author":"Nagai","year":"2021","journal-title":"Transpl Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"101147","DOI":"10.1016\/j.jhepr.2024.101147","article-title":"Waiting List Mortality and 5-Year Transplant Survival Benefit of Patients with MASLD: An Italian Liver Transplant Registry Study","volume":"6","author":"Vitale","year":"2024","journal-title":"JHEP Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1791","DOI":"10.1097\/txd.0000000000001791","article-title":"Association of Clinical, Psychosocial, and Social Determinants of Health Factors and Liver Transplantation and Waitlist Removal for MASH","volume":"11","author":"Torosian","year":"2025","journal-title":"Transpl Direct"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/ajt.17006","article-title":"Dynamic Impact of Liver Allocation Policy Change on Donor Utilization","volume":"22","author":"Chan","year":"2022","journal-title":"Am J Transpl"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/lt.26053","article-title":"The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver-Kidney Utilization and Outcomes","volume":"27","author":"Samoylova","year":"2021","journal-title":"Liver Transpl"},{"key":"B10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1200\/jco.1984.2.3.187","article-title":"Karnofsky Performance Status Revisited: Reliability, Validity, and Guidelines","volume":"2","author":"Schag","year":"1984","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e13837","DOI":"10.1111\/ctr.13837","article-title":"Liver Transplant Waitlist Outcomes in Alcoholic Hepatitis Compared with Other Liver Diseases: An Analysis of UNOS Registry","volume":"34","author":"Kitajima","year":"2020","journal-title":"Clin Transpl"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/lt.24307","article-title":"Outcomes for Liver Transplant Candidates Listed with Low Model for End-Stage Liver Disease Score","volume":"21","author":"Kwong","year":"2015","journal-title":"Liver Transpl"},{"key":"B13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.12659\/aot.914246","article-title":"Risk Factors for High Mortality on the Liver Transplant Waiting List in Times of Organ Shortage: A Single-Center Analysis","volume":"24","author":"Husen","year":"2019","journal-title":"Ann Transpl"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s10620-018-5032-5","article-title":"Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy","volume":"63","author":"Gadiparthi","year":"2018","journal-title":"Dig Dis Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/ajt.12762","article-title":"Frailty Predicts Waitlist Mortality in Liver Transplant Candidates","volume":"14","author":"Lai","year":"2014","journal-title":"Am J Transpl"},{"key":"B16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1440-1746.2006.04422.x","article-title":"Risk Factors for Liver Transplantation Waiting List Mortality","volume":"22","author":"Fink","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jamcollsurg.2020.12.021","article-title":"Racial Disparity in Liver Transplantation Listing","volume":"232","author":"Warren","year":"2021","journal-title":"J Am Coll Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/tp.0000000000002484","article-title":"Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplantation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current Concepts and Future Challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3748\/wjg.v24.i14.1491","article-title":"Nonalcoholic Fatty Liver Disease and Liver Transplantation - Where Do We Stand?","volume":"24","author":"Mikolasevic","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of Non-Alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-Analysis","volume":"11","author":"Musso","year":"2014","journal-title":"Plos Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/tp.0000000000002355","article-title":"Waiting List Mortality and Transplant Rates for NASH Cirrhosis when Compared with Cryptogenic, Alcoholic, or AIH Cirrhosis","volume":"103","author":"Thuluvath","year":"2019","journal-title":"Transplantation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1093\/cid\/ciad425","article-title":"Temporal Trends in Hepatitis C-Related Hospitalizations, United States, 2000-2019","volume":"77","author":"Hofmeister","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jhep.2018.02.012","article-title":"The Efficacy of Direct Anti-HCV Drugs Improves Early Post-Liver Transplant Survival and Induces Significant Changes in Waiting List Composition","volume":"69","author":"Crespo","year":"2018","journal-title":"J Hepatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/tp.0000000000000945","article-title":"Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States","volume":"100","author":"Singal","year":"2016","journal-title":"Transplantation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"830","DOI":"10.4254\/wjh.v13.i8.830","article-title":"Evolution of Liver Transplant Organ Allocation Policy: Current Limitations and Future Directions","volume":"13","author":"Polyak","year":"2021","journal-title":"World J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1053\/j.gastro.2018.07.025","article-title":"Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes","volume":"155","author":"Nagai","year":"2018","journal-title":"Gastroenterology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1781","DOI":"10.1097\/txd.0000000000001781","article-title":"Sex-Based Differences and Comparative Predictive Value of MELD 3.0 in Simultaneous Liver-Kidney Transplantation Waitlist Outcomes After Standardization of Listing Criteria in the United States","volume":"11","author":"Leven","year":"2025","journal-title":"Transpl Direct"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0223053","DOI":"10.1371\/journal.pone.0223053","article-title":"Use of Rapid Model for End-Stage Liver Disease (MELD) Increases for Liver Transplant Registrant Prioritization After MELD-Na and Share 35, an Evaluation Using Data from the United Network for Organ Sharing","volume":"14","author":"Brock","year":"2019","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5662\/wjm.v12.i1.32","article-title":"Liver Transplant Allocation Policies and Outcomes in United States: A Comprehensive Review","volume":"12","author":"Latt","year":"2022","journal-title":"World J Methodol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/apt.15988","article-title":"Patients with Severe Acute-on-Chronic Liver Failure Are Disadvantaged by Model for End-Stage Liver Disease-Based Organ Allocation Policy","volume":"52","author":"Sundaram","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/mot.0000000000000726","article-title":"Changes in Liver Allocation in United States","volume":"25","author":"Leventhal","year":"2020","journal-title":"Curr Opin Organ Transpl"},{"key":"B34","doi-asserted-by":"publisher","first-page":"101296","DOI":"10.1016\/j.jceh.2023.10.007","article-title":"The Effect of New Acuity Circle Policy on Simultaneous Liver and Kidney Transplantation in the United States","volume":"14","author":"Okumura","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijsu.2020.05.024","article-title":"Expanding the Donor Pool for Liver Transplantation with Marginal Donors","author":"Goldaracena","year":"2020","journal-title":"Int J Surg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"14807","DOI":"10.3389\/ti.2025.14807","article-title":"The Individual Impact of Machine Perfusion on Liver and Kidney on Donor Expansion in Simultaneous Liver and Kidney Transplantation","volume":"38","author":"Oki","year":"2025","journal-title":"Transpl Int"},{"key":"B37","doi-asserted-by":"publisher","first-page":"S457","DOI":"10.1016\/j.ajt.2024.01.018","article-title":"OPTN\/SRTR 2022 Annual Data Report: Deceased Organ Donation","volume":"24","author":"Israni","year":"2024","journal-title":"Am J Transpl"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2026.16153\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:10:15Z","timestamp":1776057015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2026.16153\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":37,"alternative-id":["10.3389\/ti.2026.16153"],"URL":"https:\/\/doi.org\/10.3389\/ti.2026.16153","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"article-number":"16153"}}